StockDuty ← Dashboard Nov 05, 2026 11:19 PM ET
SignalCorporate

Janux Therapeutics GAAP EPS of -$0.34 beats by $0.14, revenue of $9.29M beats by $2.87M

Janux EPS beat by $0.14 and revenue beat by $2.87M.

What changed
Janux EPS beat by $0.14 and revenue beat by $2.87M.
Why it matters
Janux EPS beat by $0.14 and revenue beat by $2.87M. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →